Skip to content

Drug interactions

Irbesartan + Lonafarnib

Severity: Minor

Irbesartan and Lonafarnib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lonafarnib is a sensitive CYP3A substrate, but irbesartan is not a CYP3A inhibitor. No meaningful rise in lonafarnib exposure is expected.

What this interaction means in plain words

Irbesartan and Lonafarnib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Irbesartan belongs to Cardiovascular; Lonafarnib belongs to Miscellaneous.

Evidence level: Low

Why it happens

No established mechanism; irbesartan does not inhibit CYP3A4 to a relevant extent.

What to do

No dose adjustment needed; follow routine monitoring for lonafarnib adverse effects.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Irbesartan and Lonafarnib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Irbesartan with Lonafarnib?

MediHelp rates the interaction as minor. Irbesartan and Lonafarnib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lonafarnib is a sensitive CYP3A substrate, but irbesartan is not a CYP3A inhibitor. No meaningful rise in lonafarnib exposure is expected.

How serious is the interaction between Irbesartan and Lonafarnib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment needed; follow routine monitoring for lonafarnib adverse effects.

What other medicines interact with Irbesartan?

MediHelp also lists interactions of Irbesartan with, for example, Aliskiren, Sparsentan, Amifostine. The full list is on the Irbesartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in